Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan-Fan Hou

Showing results (1-10 of 349) with videos related to

Pageof 35
Sort By:
Chinese Medical Journal|August 15, 2008
Pharmacological intervention of hypertension in proteinuric chronic kidney disease: how and what?Fan-Fan Hou
Chinese Medical Journal|June 28, 2005
Cardiovascular risk in Chinese patients with chronic kidney diseases: where do we stand?Fan-fan Hou
Kidney Diseases (Basel, Switzerland)|February 25, 2017
Advances in the Management of Acute Cardiorenal Syndrome in China: Biomarkers for Predicting Development and OutcomesFan Fan Hou, Xiaobing Yang
Chinese Medical Journal|March 16, 2007
How should renin-angiotensin system blockade be applied in chronic kidney disease for optimal renal protection?Xun Zhang, Fan-fan Hou
Zhonghua Nei Ke Za Zhi|October 29, 2010
[Calcium and phosphorus metabolism and cardiovascular disease in chronic kidney disease]Xun Zhang, Fan-fan Hou
Kidney International Supplements|August 28, 2015
New insights into the pathogenesis and therapeutics of kidney fibrosisFan Fan Hou, Youhua Liu
JAMA Internal Medicine|February 7, 2017
The Nephroprotective Effect of Folic Acid-Only a Matter of Homocysteine?-ReplyFan Fan Hou, Xin Xu
Chinese Medical Journal|August 14, 2012
Role of reactive oxygen species in the renal fibrosisJing Nie, Fan-Fan Hou
Current Opinion in Nephrology and Hypertension|July 10, 2002
Beta 2-microglobulin amyloidosis: role of monocytes/macrophagesFan Fan Hou, William F Owen
Nephrology (Carlton, Vic.)|July 1, 2010
Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotectionFan Fan Hou, Qiu Gen Zhou
Pageof 35

Showing results (1-10 of 349) with videos related to

Sort By:
Pageof 35
Chinese Medical Journal|August 15, 2008
Pharmacological intervention of hypertension in proteinuric chronic kidney disease: how and what?Fan-Fan Hou
Chinese Medical Journal|June 28, 2005
Cardiovascular risk in Chinese patients with chronic kidney diseases: where do we stand?Fan-fan Hou
Kidney Diseases (Basel, Switzerland)|February 25, 2017
Advances in the Management of Acute Cardiorenal Syndrome in China: Biomarkers for Predicting Development and OutcomesFan Fan Hou, Xiaobing Yang
Chinese Medical Journal|March 16, 2007
How should renin-angiotensin system blockade be applied in chronic kidney disease for optimal renal protection?Xun Zhang, Fan-fan Hou
Zhonghua Nei Ke Za Zhi|October 29, 2010
[Calcium and phosphorus metabolism and cardiovascular disease in chronic kidney disease]Xun Zhang, Fan-fan Hou
Kidney International Supplements|August 28, 2015
New insights into the pathogenesis and therapeutics of kidney fibrosisFan Fan Hou, Youhua Liu
JAMA Internal Medicine|February 7, 2017
The Nephroprotective Effect of Folic Acid-Only a Matter of Homocysteine?-ReplyFan Fan Hou, Xin Xu
Chinese Medical Journal|August 14, 2012
Role of reactive oxygen species in the renal fibrosisJing Nie, Fan-Fan Hou
Current Opinion in Nephrology and Hypertension|July 10, 2002
Beta 2-microglobulin amyloidosis: role of monocytes/macrophagesFan Fan Hou, William F Owen
Nephrology (Carlton, Vic.)|July 1, 2010
Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotectionFan Fan Hou, Qiu Gen Zhou
Pageof 35